13D Filing: Tang Capital Partners LP and Odonate Therapeutics Inc (ODT)

Page 8 of 14

Page 8 of 14 – SEC Filing

Shared power to vote or direct the vote:
Tang Capital Partners, LP
12,202,338 shares
Tang Capital Management, LLC
12,202,338 shares
Kevin C. Tang
12,202,338 shares
Sole power to dispose or direct the disposition:
Tang Capital Partners, LP
0 shares
Tang Capital Management, LLC
0 shares
Kevin C. Tang
0 shares
Shared power to dispose or direct the disposition:
Tang Capital Partners, LP
12,202,338 shares
Tang Capital Management, LLC
12,202,338 shares
Kevin C. Tang
12,202,338 shares
(c)          The Reporting Persons have engaged in the following transactions in the Issuer’s Common Stock during the last 60 days:
Entity
Transaction
Trade Date
Shares
Price/Share
Tang Capital Partners, LP
Purchase
December 7, 2017
           1,291,666
          $24.00
(e)          N/A.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
Reference is made to the relationships described in Item 5(a) of this Statement.
The Reporting Persons have entered into a Joint Filing Agreement. See Item 2.
The shares reported as beneficially owned by the Reporting Persons include a total of 154,285 shares of Common Stock that are held of record by Holdings. Holdings has granted a proxy to Tang Capital Partners, LP giving Tang Capital Partners, LP the authority to vote such shares. The irrevocable proxy terminates upon the distribution of the shares subject to the irrevocable proxy to Tang Capital Partners, LP or the written agreement of the parties. The foregoing description is only a summary and is qualified in its entirety by reference to the complete text of the proxy, the form of which is filed as Exhibit 2 hereto.

Follow Odonate Therapeutics Inc. (NASDAQ:ODT)

Page 8 of 14